23andMe

23andMe is an online healthcare platform that provides DNA genetic testing for individuals and uses that information for health research.

Business Model:

Revenue: $271.9M

Employees: 501-1,000

Detailed 23andMe Information

Geographic Data

23andMe headquarters map

Address: 349 Oyster Point Blvd,

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$250M

Raised Total:

$1B

Metrics

13,982Website Global Rank

9,202,122Website Monthly Traffic

Twitter Followers

Description

23andMe is an online healthcare platform that provides DNA genetic testing for individuals and uses that information for health research.

Contact Phone:
+16509386300

Contact Email:

23andMe went public on 6/17/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/17/2021

IPO Valuation:
$4B

Ticker Symbol:
ME

IPO Price:
$11/share

Amount Raised:
$592M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
7/2015 Doctor On Demand Series B 0
7/2015 Doctor On Demand Series B 0
Announced Date Transaction Number of Investors Money Raised Lead Investors
10/2015 Series E 9 $115M Xfund
WuXi Healthcare Ventures
New Enterprise Associates
MPM Capital
Lauder Partners
Illumina Ventures
GV
EquityZen
Casdin Capital
Xfund
WuXi Healthcare Ventures
New Enterprise Associates
MPM Capital
Lauder Partners
Illumina Ventures
GV
EquityZen
Casdin Capital
1/2011 Series C 2 $9M MPM Capital
Johnson &a; Johnson Development Corporation
MPM Capital
Johnson &a; Johnson Development Corporation
11/2010 Series C 3 $22.2M New Enterprise Associates
Johnson &a; Johnson Development Corporation
GV
New Enterprise Associates
Johnson &a; Johnson Development Corporation
GV
6/2021 Post-IPO Equity 6 $250M Richard Branson
Altimeter Capital
Anne Wojcicki
Foresite Capital
Fidelity Management and Research Company
Casdin Capital
Richard Branson
Altimeter Capital
Anne Wojcicki
Foresite Capital
Fidelity Management and Research Company
Casdin Capital
10/2017 Secondary Market 3 - SharesPost Investment Management
James Sowers
Employee Stock Option Fund
SharesPost Investment Management
James Sowers
Employee Stock Option Fund
12/2009 Series B $14.2M
9/2017 Series F $0 Sequoia Capital
Altimeter Capital
Casdin Capital
Euclidean Capital
Fidelity
G Squared
Nimble Ventures
Wallenberg Foundations
Sequoia Capital
Altimeter Capital
Casdin Capital
Euclidean Capital
Fidelity
G Squared
Nimble Ventures
Wallenberg Foundations
12/2012 Series D 5 $50M Sergey Brin
New Enterprise Associates
MPM Capital
GV
Anne Wojcicki
Sergey Brin
New Enterprise Associates
MPM Capital
GV
Anne Wojcicki
6/2009 Series B 3 $13.6M Sergey Brin
New Enterprise Associates
Google
Sergey Brin
New Enterprise Associates
Google
10/2007 Series A $0 Genentech
Google
Mohr Davidow Ventures
New Enterprise Associates
Stephens Investment Management
Wendi Murdoch
Genentech
Google
Mohr Davidow Ventures
New Enterprise Associates
Stephens Investment Management
Wendi Murdoch
10/2018 Series F 1 - Rancilio Cube
Rancilio Cube
12/2020 Series F 4 $82.5M Pegasus Tech Ventures
Sequoia Capital
NewView Capital
ACE &a; Company
NewView Capital
Sequoia Capital
Pegasus Tech Ventures
Sequoia Capital
NewView Capital
ACE &a; Company
NewView Capital
Sequoia Capital
7/2018 Corporate Round 1 $300M GlaxoSmithKline
GlaxoSmithKline
11/2010 Debt Financing -
10/2016 Grant 1 $1.7M National Institutes of Health
National Institutes of Health
3/2021 IPO $592M
7/2018 Equity $300M GlaxoSmithKline
9/2017 Venture Round $250M Sequoia Capital
8/2017 Series F -
4/2018 Secondary Market 1 - 10X Capital
10X Capital
7/2014 Grant 1 $1.4M National Institutes of Health
National Institutes of Health
1/2019 Secondary Market 2 - Raj Luhar
Future Planet Capital
Raj Luhar
Future Planet Capital
12/2020 Series F $82.5M Sequoia Capital
Xfund
1/2019 Secondary Market 2 -
10/2018 Series F 1 -
4/2018 Secondary Market 1 -
10/2017 Secondary Market 3 -
9/2017 Series F 8 $250M Sequoia Capital
Sequoia Capital
8/2017 Series F -
Announced Date Name Price
10/2021 Lemonaid Health
7/2012 CureTogether

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research